Comprehensive Stereotactic Radiation Therapy for Oligometastatic Prostate Cancer: A Phase I/II Study
This is a study that assesses the safety and efficacy of using stereotactic radiation therapy in
conjunction with hormone therapy for patients with metastatic prostate cancer where there
are a limited number of metastatic tumours.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society